About CIRC Biosciences
CIRC Biosciences is a private company based in Chicago, Illinois, incorporated in 2019 in Delaware. It has reported $24,085,000 raised in three offerings on Form D since December 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 1, 2024 | Oct 7, 2024 | $250,000fully sold | 1 | $250K | Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 15, 2024 | May 1, 2024 | $7,000,000fully sold | 19 | $368K | DebtRule 506(b) | Form D ↗ |
| Oct 23, 2020 | Dec 7, 2020 | $16,835,000fully sold | 3 | $5.6M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $24,085,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CIRC Biosciences's Form D filed Oct 7, 2024.
DP
Darien Parhad
Executive officer
Also an executive officer at Castle Creek Biosciences and Paragon Biosciences Emalex Capital and a chief financial officer and treasurer at Evozyne.
TC
Timothy Cunniff
Director
Also a director at Castle Creek Biosciences and Paragon Biosciences Emalex Capital.
PM
Patrick Morris
President, Secretary and General Counsel, director
Also a director at Castle Creek Biosciences, an executive officer and director at Evozyne and an executive vice president and secretary at Paragon Biosciences Emalex Capital.
SC
Sai Chavala
Director
AG
Antonio Gracias
Director
Also a director at Castle Creek Biosciences, Evozyne and Paragon Biosciences Emalex Capital.
JA
Jeffrey Aronin
Director
Also a director at Castle Creek Biosciences and Paragon Biosciences Emalex Capital and a chairman and director at Evozyne.